PatientsVille.com Logo

PatientsVille

Microgynon Side Effects

Common Microgynon Side Effects


The most commonly reported Microgynon side effects (click to view or check a box to report):

Maternal Exposure During Pregnancy (3)
Musculoskeletal Stiffness (3)
Abortion Induced (3)
Haematoma (3)
Erythema (3)
Placental Disorder (3)
Lupus-like Syndrome (3)
Pregnancy (3)
Skin Lesion (3)
Swelling (3)
Rash (3)
Rash Erythematous (3)
Gastrointestinal Carcinoma (2)
Eye Infection (2)
Eye Disorder (2)
Liver Disorder (2)
Surgery (2)
Pain (2)
Thrombosis (2)
Toxoplasmosis (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Microgynon Side Effects Reported to FDA

The following Microgynon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Microgynon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Deep Vein Thrombosis
This is a report of a 46-year-old female patient (weight: NA) from NL, suffering from the following symptoms/conditions: contraception, who was treated with Microgynon 30 (dosage: Unk, start time: 200301), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Deep Vein Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Microgynon 30 treatment in female patients, resulting in deep vein thrombosis side effect.

Amenorrhoea, Abdominal Distension, Dysmenorrhoea, Irritability, Withdrawal Syndrome
This report suggests a potential Microgynon Amenorrhoea, Abdominal Distension, Dysmenorrhoea, Irritability, Withdrawal Syndrome side effect(s) that can have serious consequences. A 28-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: contraception and used Microgynon (dosage: Unk) starting 201205. Soon after starting Microgynon the patient began experiencing various side effects, including:
  • Amenorrhoea
  • Abdominal Distension
  • Dysmenorrhoea
  • Irritability
  • Withdrawal Syndrome
Drugs used concurrently:
  • Yasmin, Film-coated Tablets, 0.03 Mg/3 Mg (Unk)
Although Microgynon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as amenorrhoea, may still occur.

Abortion Induced, Placental Disorder, Pregnancy, Haematoma
This Abortion Induced, Placental Disorder, Pregnancy, Haematoma problem was reported by a health professional from . A 20-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Dec 01, 2006 this consumer started treatment with Microgynon (eugynon /00022701/) (dosage: NA). The following drugs were being taken at the same time:
  • Lamotrigine (200 Mg (100 Mg,2 In 1 D),oral)
  • Folic Acid
When commencing Microgynon (eugynon /00022701/), the patient experienced the following unwanted symptoms/side effects:
  • Abortion Induced
  • Placental Disorder
  • Pregnancy
  • Haematoma
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as abortion induced, may become evident only after a product is in use by the general population.

Maternal Exposure During Pregnancy, Abortion Induced, Placental Disorder, Haematoma
This is a report of a 20-year-old female patient (weight: NA) from UNITED KINGDOM. The patient developed the following symptoms/conditions: NA and was treated with Microgynon (eugynon /00022701/) (dosage: NA) starting Dec 01, 2006. Concurrently used drugs:
  • Lamotrigine (100 Mg, 2 In 1 D, Oral)
  • Folic Acid
Soon after that, the consumer experienced the following side effects:
  • Maternal Exposure During Pregnancy
  • Abortion Induced
  • Placental Disorder
  • Haematoma
This opens a possibility that Microgynon (eugynon /00022701/) treatment could cause the above reactions, including maternal exposure during pregnancy, and some female subjects may be more susceptible.


Abortion Induced, Pregnancy, Haematoma, Placental Disorder, Maternal Exposure During Pregnancy
A 20-year-old female patient (weight: NA) from with the following symptoms/conditions: NA started Microgynon (eugynon / /2007 - /00022701/) treatment (dosage: NA) on Dec 01, 2006. Soon after starting Microgynon (eugynon / /2007 - /00022701/) treatment, the subject experienced various side effects, including:
  • Abortion Induced
  • Pregnancy
  • Haematoma
  • Placental Disorder
  • Maternal Exposure During Pregnancy
Concurrently used drugs:
  • Lamotrigine (200 Mg (100 Mg, 2 In 1 D), Oral)
  • Folic Acid
This finding indicates that some female patients could be more vulnerable to Microgynon (eugynon / /2007 - /00022701/).

Maternal Exposure During Pregnancy, Nausea, Pregnancy On Oral Contraceptive, Abortion Spontaneous
A 22-year-old female patient from NETHERLANDS (weight: NA) experienced symptoms, such as: oral contraception and was treated with Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le(dosage: NA). The treatment was initiated on Jan 01, 2010. After that a consumer reported the following side effect(s):
  • Maternal Exposure During Pregnancy
  • Nausea
  • Pregnancy On Oral Contraceptive
  • Abortion Spontaneous
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le efficacy:
  • Atorvastatine (atorvastatin) (atorvastatin)
  • Colesevelam (colesevelam) (625 Milligram, Tablet) (colesevelan) (3750 Mg, Per Oral ; 3125 Mg,per Oral)
  • Colesevelam (colesevelam) (625 Milligram, Tablet) (colesevelan) (3750 Mg, Per Oral ; 3125 Mg,per Oral)
  • Ezetimibe


Appendiceal Abscess
In this report, Microgynon 30 was administered for the following condition: contraception,multiple sclerosis.A 34-year-old female consumer from AUSTRALIA (weight: NA) started Microgynon 30 treatment (dosage: NA) on Mar 01, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Appendiceal Abscess
A possible interaction with other drugs could have contributed to this reaction:
  • Avonex
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Microgynon 30 treatment could be related to the listed above side effect(s).

Alcohol Use, Completed Suicide
This is a report of the following Microgynon /00022701/ side effect(s):
  • Alcohol Use
  • Completed Suicide
A 17-year-old female patient from UNITED KINGDOM (weight: NA) presented with the following condition: NA and received a treatment with Microgynon /00022701/ (dosage: NA) starting: Jan 19, 2011.The following concurrently used drugs could have generated interactions:
  • Nexplanon (etonogestrel / 01502301/) (68 Mg, Sbde)
  • Lidocaine
This report suggests that a Microgynon /00022701/ treatment could be associated with the listed above side effect(s).

Arthralgia, Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Rash, Rash Erythematous, Skin Lesion, Swelling
This Microgynon report was submitted by a 32-year-old female consumer from UNITED KINGDOM (weight: NA). The patient was diagnosed with: contraception,insomnia,depression,osteopenia,fatigue and Microgynon was administered (dosage: NA) starting: Feb 01, 2006. The consumer developed a set of symptoms:
  • Arthralgia
  • Erythema
  • Lupus-like Syndrome
  • Musculoskeletal Stiffness
  • Rash
  • Rash Erythematous
  • Skin Lesion
  • Swelling
Other drugs used simultaneously:
  • Nifedipine
  • Amitriptline Hcl
  • Calcichew
  • Provigil
  • Provigil
  • Provigil
  • Multi-vitamin
Those unexpected symptoms could be linked to a Microgynon treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, Swelling
This is a report of a possible correlation between Microgynon use and the following symptoms/side effect(s):
  • Erythema
  • Lupus-like Syndrome
  • Musculoskeletal Stiffness
  • Pain
  • Rash
  • Rash Erythematous
  • Skin Lesion
  • Swelling
which could contribute to an assessment of Microgynon risk profile.A 31-year-old female consumer from UNITED KINGDOM (weight: NA) was suffering from contraception,insomnia,depression,osteopenia,fatigue and was treated with Microgynon (dosage: NA) starting Feb 01, 2005.Other concurrent medications:
  • Nifedipine
  • Amitriptyline Hcl
  • Calcichew
  • Provigil


Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, Swelling
A 31-year-old female patient from UNITED KINGDOM (weight: NA) presented with the following symptoms: contraception,insomnia,depression,osteopenia,fatigue and after a treatment with Microgynon (dosage: NA) experienced the following side effect(s):
  • Erythema
  • Lupus-like Syndrome
  • Musculoskeletal Stiffness
  • Pain
  • Rash
  • Rash Erythematous
  • Skin Lesion
  • Swelling
The treatment was started on Feb 01, 2005. Microgynon was used in combination with the following drugs:
  • Nifedipine
  • Amitriptyline Hcl
  • Calcichew
  • Provigil
This report could alert potential Microgynon consumers.

Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis
In this report, a 21-year-old female patient from UNITED KINGDOM (weight: NA) was affected by a possible Microgynon 30 (21) side effect.The patient was diagnosed with NA. After a treatment with Microgynon 30 (21) (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Eye Disorder
  • Eye Infection
  • Thrombosis
  • Toxoplasmosis
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Microgynon 30 (21) treatment.

Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis
This is a report of a 21-year-old female patient from UNITED KINGDOM (weight: NA), who used Microgynon 30 (21) (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Eye Disorder
  • Eye Infection
  • Thrombosis
  • Toxoplasmosis
The following drugs could possibly have interacted with the Microgynon 30 (21) treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Microgynon 30 (21) treatment could be related to side effect(s), such as Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, Surgery
This alanine aminotransferase increased side effect was reported by a physician from BELGIUM. A 50-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Microgynon (dosage: NA), which was started on Nov 07, 2005. Concurrently used drugs:
  • Bisoprolol Fumarate W/hydrochlorothiazide
  • Lamisil (250 Mg/d)
When starting to take Microgynon the consumer reported the following symptoms:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Gastrointestinal Carcinoma
  • Liver Disorder
  • Surgery
These side effects may potentially be related to Microgynon.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, Surgery
This is a Microgynon side effect report of a 50-year-old female patient (weight:NA) from BELGIUM, suffering from the following symptoms/conditions: NA, who was treated with Microgynon (dosage:NA, start time: Nov 07, 2005), combined with:
  • Bisoprolol Fumarate W/hydrochlorothiazide
  • Lamisil (250 Mg/d)
, and developed a serious reaction and a alanine aminotransferase increased side effect. The patient presented with:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Gastrointestinal Carcinoma
  • Liver Disorder
  • Surgery
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Microgynon treatment in female patients suffering from NA, resulting in alanine aminotransferase increased.

Antiphospholipid Antibodies Positive, Cardiolipin Antibody Positive, Mesenteric Artery Thrombosis, Portal Vein Thrombosis
This report suggests a potential Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet antiphospholipid antibodies positive side effect(s) that can have serious consequences. A 35-year-old female patient from SPAIN (weight:NA) was diagnosed with the following health condition(s): NA and used Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet (dosage: 1 Tab (s), Oral) starting Dec 01, 2005. Soon after starting Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet the patient began experiencing various side effects, including:
  • Antiphospholipid Antibodies Positive
  • Cardiolipin Antibody Positive
  • Mesenteric Artery Thrombosis
  • Portal Vein Thrombosis
Drugs used concurrently:NA. Although Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as antiphospholipid antibodies positive, may still occur.



Top 10 Microgynon Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Microgynon Side Effects

    Did You Have a Microgynon Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Microgynon for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective